Lung Cancer (Google eBook)

Front Cover
Jack A. Roth, James D. Cox, Waun Ki Hong
John Wiley & Sons, Aug 26, 2011 - Medical - 480 pages
0 Reviews
Lung cancer is a major cause of cancer-related deaths in men and women. However, since the first edition of Lung Cancer was published 14 years ago, rapid progress in the biology, prevention, diagnosis, and treatment of the disease has been made.

This outstanding team from the M.D. Anderson Cancer Center takes an evidence-based approach to lung cancer management and explains these advances in depth. Comprehensive treatment guidelines are provided, the third edition of Lung Cancer explores vital issues such as:

  • Lung cancer susceptibility and risk assessment

  • The pathology and pathogenesis of peripheral lung adenocarcinoma including bronchioloalveolar carcinoma

  • Screening for early detection

  • Advances in molecular and genetic markers

  • The detection and treatment of pre-neoplastic lesions and screening for lung cancer

  • Novel therapies such as angiogenesis and multi-tyrosine kinase inhibitors

Lung Cancer is a concise summary of advances in lung cancer clinical research and treatment for the clinician and is an invaluable reference for respiratory physicians, medical oncologists, clinical and surgical oncologists.


What people are saying - Write a review

We haven't found any reviews in the usual places.


Smoking Cessation
Lung Cancer Susceptibility Genes
Lung Cancer Susceptibility and Risk
The Molecular Genetics of Lung Cancer
Molecular Biology of Preneoplastic Lesions
Detection of Preneoplastic Lesions
Surgical morbidity and mortality after induction therapy
ImageGuided Radiation Therapy
Stereotactic Body Radiation Therapy for Lung
Immobilization and target motion issues related to SBRT
Proton Therapy
Combinations of Radiation Therapy
New Chemotherapeutic Agents in Lung Cancer

Treatment of Preneoplastic Lesions of the Lung
The Pathology and Pathogenesis of Peripheral
Rateadaptive Pacing
Molecular Profiling for Early Detection
The Role for Mediastinoscopy in the Staging
Redo mediastinoscopy
Minimally Invasive Surgepy for Lung Cancer
Extended Resections for Lung Cancer
Adiuvant Chemotherapy Following Surgery
Induction Chemotherapy for Resectable Lung
Randomized phase II and phase III trials
Immunologic Approaches to Lung Cancer
Epidermal Growth Factor Receptor Inhibitors
Tumor Angiogenesis Biology and Therapeutic
Retinoids and Rexinoids in Lung Cancer
Proteasome Inhibition in Nonsmall Cell Lung
Targeted Genetic Therapy for Lung Cancer
Screening for Early Detection
Natural Agents for Chemoprevention of Lung
Color plates are found facing

Common terms and phrases

About the author (2011)

Jack A. Roth, MD FACS, Professor and Chairman, Bud Johnson Clinical Distinguished Chair, The University of Texas M.D. Anderson Cancer Center, Department of Thoracic & Cardiovascular Surgery and Professor of Molecular and Cellular Oncology, Director, W.M. Keck Center for Cancer Gene Therapy, Houston, Texas, USA.

James D. Cox, MD, Professor and Head, Division of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.

Waun Ki Hong, MD, American Cancer Society Clinical Research Professor, Charles A. LeMistre Distinguished Chair in Thoracic Oncology and Professor and Chairman, Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.

Bibliographic information